Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The New Yorker features our Head of Department Professor Irene Tracey, and her research into the neuroscience of pain.

© Rebecca Rumble

New Yorker journalist Nicola Twilley came over to Oxford in February to meet Irene Tracey and find out about her life's work on the neuroscience of pain. She was lucky enough to experience the MRI scanner in our Wellcome Centre for Integrative Neuroimaging, as well as spending some time in the clinical pain testing lab.

...this is everything I’ve been looking for. It’s got clinical application, interesting philosophy, and we know absolutely nothing...Right, that’s it, pain is going to be my thing.
- Professor Irene Tracey, Head of Department

The feature length article covers the genesis of Irene's interest in pain, and charts her experiments over the years that have earned her the nickname 'Queen of Pain' in the research community.

Twilley presents a fascinating insight into Irene's work, concluding that 'her findings have already changed our understanding of pain; now they promise to transform its diagnosis and treatment, a shift whose effects will be felt in hospitals, courtrooms, and society at large.'

Read the full article on the New Yorker website

Similar stories

Bioelectronic implant offers an intelligent therapy to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their 'smart' bioelectronic implants.

Direct evidence of reduced NMDA receptors in people with form of encephalitis

NMDAR-antibody encephalitis is an autoimmune brain condition caused by patient’s own antibodies that bind to NMDA (N-Methyl-D-Aspartate) receptors in the synapses between nerve cells.

Director of MRC Brain Network Dynamics Unit appointed

From 2 January 2023, Professor Peter Magill will lead the Medical Research Council Brain Network Dynamics Unit (MRC BNDU) at the University of Oxford.

Study reveals association between diagnosis of a neuropsychiatric condition and severe outcome from COVID-19 infection, and other severe acute respiratory infections

New research from the University of Oxford has shown an increased risk of severe illness and death from both COVID-19 and other severe respiratory infections, such as influenza and pneumonia, among people with a pre-existing mental health condition.

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.